Towards safe, non-viral therapeutic gene expression in humans

The potential dangers of using viruses to deliver and integrate DNA into host cells in gene therapy have been poignantly highlighted in recent clinical trials. Safer, non-viral gene delivery approaches have been largely ignored in the past because of their inefficient delivery and the resulting transient transgene expression. However, recent advances indicate that efficient, long-term gene expression can be achieved by non-viral means. In particular, integration of DNA can be targeted to specific genomic sites without deleterious consequences and it is possible to maintain transgenes as small episomal plasmids or artificial chromosomes. The application of these approaches to human gene therapy is gradually becoming a reality.

[1]  K. Rajewsky,et al.  Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: A tool for efficient genetic engineering of mammalian genomes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  D. Jans,et al.  Enhancement of MSH receptor- and GAL4-mediated gene transfer by switching the nuclear import pathway , 2001, Gene Therapy.

[3]  C. Barbas,et al.  Fusion Proteins Consisting of Human Immunodeficiency Virus Type 1 Integrase and the Designed Polydactyl Zinc Finger Protein E2C Direct Integration of Viral DNA into Specific Sites , 2004, Journal of Virology.

[4]  V. Oberle,et al.  Efficient transfer of chromosome-based DNA constructs into mammalian cells. , 2004, Biochimica et biophysica acta.

[5]  D. Gruenert,et al.  Application of SFHR to gene therapy of monogenic disorders , 2002, Gene Therapy.

[6]  A. Alazami,et al.  Human artificial chromosomes containing chromosome 17 alphoid DNA maintain an active centromere in murine cells but are not stable. , 2004, Genomics.

[7]  Prerna Sharma,et al.  Circular Intermediates of Recombinant Adeno-Associated Virus Have Defined Structural Characteristics Responsible for Long-Term Episomal Persistence in Muscle Tissue , 1998, Journal of Virology.

[8]  C. Hsieh.  In Vivo Activity of Murine De Novo Methyltransferases, Dnmt3a and Dnmt3b , 1999, Molecular and Cellular Biology.

[9]  D. Esposito,et al.  Protein and DNA requirements of the bacteriophage HP1 recombination system: a model for intasome formation. , 2001, Nucleic acids research.

[10]  Sandra Goetze,et al.  Chromatin loops are selectively anchored using scaffold/matrix-attachment regions , 2004, Journal of Cell Science.

[11]  N. Philpott,et al.  Transgene expression after rep-mediated site-specific integration into chromosome 19. , 2004, Human gene therapy.

[12]  D. Price,et al.  Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice , 1993, Nature Genetics.

[13]  K. Mislick,et al.  Evidence for the role of proteoglycans in cation-mediated gene transfer. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  R. Schwartz,et al.  Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences , 1999, Nature Biotechnology.

[15]  Frank Buchholz,et al.  Alteration of Cre recombinase site specificity by substrate-linked protein evolution , 2001, Nature Biotechnology.

[16]  Dan Ferber,et al.  Safer and Virus-Free? , 2001, Science.

[17]  W. Wels,et al.  A Modular DNA Carrier Protein Based on the Structure of Diphtheria Toxin Mediates Target Cell-specific Gene Delivery* , 1998, The Journal of Biological Chemistry.

[18]  P. Khavari,et al.  φC31 Integrase-Mediated Nonviral Genetic Correction of Junctional Epidermolysis Bullosa , 2003 .

[19]  J. Behr,et al.  Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[20]  C. Magin-Lachmann,et al.  In vitro and in vivo delivery of intact BAC DNA – comparison of different methods , 2004, The journal of gene medicine.

[21]  D. Jans,et al.  Gene therapy: optimising DNA delivery to the nucleus. , 2001, Current drug targets.

[22]  D. Prasher,et al.  Removal of a cryptic intron and subcellular localization of green fluorescent protein are required to mark transgenic Arabidopsis plants brightly. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[23]  N. Fairweather,et al.  A Multi-domain Protein System Based on the HC Fragment of Tetanus Toxin for Targeting DNA to Neuronal Cells , 2003, Journal of drug targeting.

[24]  M. Jayaram,et al.  A general model for site-specific recombination by the integrase family recombinases. , 1999, Nucleic acids research.

[25]  C. Benham,et al.  Computational and in vitro analysis of destabilized DNA regions in the interferon gene cluster: potential of predicting functional gene domains. , 2003, Biochemistry.

[26]  A. Baiker,et al.  Exploiting a minimal system to study the epigenetic control of DNA replication: the interplay between transcription and replication , 2004, Chromosome Research.

[27]  V. Schmitz,et al.  Requirements for Adeno-Associated Virus-Derived Non-Viral Vectors to Achieve Stable and Site-Specific Integration of Plasmid DNA in Liver Carcinoma Cells , 2003, Digestion.

[28]  H. Lipps,et al.  Expression of a transgene encoded on a non-viral episomal vector is not subject to epigenetic silencing by cytosine methylation , 2004, Molecular Biology Reports.

[29]  C. Keller,et al.  The Origin Recognition Complex Marks a Replication Origin in the Human TOP1 Gene Promoter* , 2002, The Journal of Biological Chemistry.

[30]  P. Fan,et al.  Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. , 1996, Human gene therapy.

[31]  H. Lipps,et al.  An episomal mammalian replicon: sequence‐independent binding of the origin recognition complex , 2004, The EMBO journal.

[32]  R. Kandolf,et al.  Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87. , 2003, Carcinogenesis.

[33]  Ralf Kühn,et al.  Enhanced efficiency through nuclear localization signal fusion on phage PhiC31-integrase: activity comparison with Cre and FLPe recombinase in mammalian cells. , 2002, Nucleic acids research.

[34]  D. Price,et al.  Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected]. , 1993, Nature genetics.

[35]  Eric C. Olivares,et al.  A phage integrase directs efficient site-specific integration in human cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Kay,et al.  Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[37]  W. Hammerschmidt,et al.  The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  H. Koyama,et al.  Site-specific integration of adeno-associated virus-based plasmid vectors in lipofected HeLa cells. , 2000, Virology.

[39]  Christof von Kalle,et al.  A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. , 2003, The New England journal of medicine.

[40]  R. Scharfmann,et al.  Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Rosanna Martinelli,et al.  Short and highly efficient synthetic promoters for melanoma‐specific gene expression , 2005, FEBS letters.

[42]  D. Schindelhauer,et al.  Mammalian artificial chromosome formation from circular alphoid input DNA does not require telomere repeats. , 2000, Human molecular genetics.

[43]  Robert E. White,et al.  Functional delivery of large genomic DNA to human cells with a peptide‐lipid vector , 2003, The journal of gene medicine.

[44]  P. Nielsen,et al.  Localization and dynamics of small circular DNA in live mammalian nuclei. , 2004, Nucleic acids research.

[45]  R. Kapsa,et al.  In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement. , 2001, Human gene therapy.

[46]  Robert E. White,et al.  Stable correction of a genetic deficiency in human cells by an episome carrying a 115 kb genomic transgene , 2000, Nature Biotechnology.

[47]  Theresa A. Storm,et al.  AAV serotype 2 vectors preferentially integrate into active genes in mice , 2003, Nature Genetics.

[48]  Eric C. Olivares,et al.  Site-specific genomic integration produces therapeutic Factor IX levels in mice , 2002, Nature Biotechnology.

[49]  Robert E. White,et al.  Sequences Adjacent to oriP Improve the Persistence of Epstein-Barr Virus-Based Episomes in B Cells , 2001, Journal of Virology.

[50]  F. Bushman,et al.  Tethering human immunodeficiency virus 1 integrase to a DNA site directs integration to nearby sequences. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[51]  D. Price,et al.  Erratum: Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice (Nature Genetics (1993) 5 (22-30)) , 1993 .

[52]  N. Phillips,et al.  Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. , 1997, Biochimica et biophysica acta.

[53]  D. Ferber.  Gene therapy. Safer and virus-free? , 2001, Science.

[54]  F. Szoka,et al.  Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes* , 2003, Journal of Biological Chemistry.

[55]  E. Wagner,et al.  Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application , 2001, Gene Therapy.

[56]  E. Galun,et al.  Imaging transgene expression in live animals. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[57]  R. Linden,et al.  Adeno-associated virus site-specifically integrates into a muscle-specific DNA region. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[58]  K. Tamayose,et al.  Site-Specific Integration of an Adeno-Associated Virus Vector Plasmid Mediated by Regulated Expression of Rep Based on Cre-loxP Recombination , 2000, Journal of Virology.

[59]  Mark A. Kay,et al.  Progress and problems with the use of viral vectors for gene therapy , 2003, Nature Reviews Genetics.

[60]  Eric C. Olivares,et al.  Site-Specific Genomic Integration in Mammalian Cells Mediated by Phage φC31 Integrase , 2001, Molecular and Cellular Biology.

[61]  R. Hollis,et al.  Phage integrases for the construction and manipulation of transgenic mammals , 2003, Reproductive biology and endocrinology : RB&E.

[62]  A. Belmaaza,et al.  Promoter suppression in cultured mammalian cells can be blocked by the chicken beta-globin chromatin insulator 5'HS4 and matrix/scaffold attachment regions. , 2001, Journal of molecular biology.

[63]  J. Decaprio,et al.  Structure of the replicative helicase of the oncoprotein SV40 large tumour antigen , 2003, Nature.

[64]  N. Christ,et al.  Site-specific recombination in eukaryotic cells mediated by mutant lambda integrases: implications for synaptic complex formation and the reactivity of episomal DNA segments. , 2002, Journal of molecular biology.

[65]  Shawn M. Burgess,et al.  Transcription Start Regions in the Human Genome Are Favored Targets for MLV Integration , 2003, Science.

[66]  S. Weger,et al.  Kinetics and Frequency of Adeno-Associated Virus Site-Specific Integration into Human Chromosome 19 Monitored by Quantitative Real-Time PCR , 2002, Journal of Virology.

[67]  K. Choo,et al.  Analysis of Mitotic and Expression Properties of Human Neocentromere-based Transchromosomes in Mice* , 2005, Journal of Biological Chemistry.

[68]  P. Angrand,et al.  Improved properties of FLP recombinase evolved by cycling mutagenesis , 1998, Nature Biotechnology.

[69]  B. Thyagarajan,et al.  Directed evolution of a recombinase for improved genomic integration at a native human sequence. , 2001, Nucleic acids research.

[70]  H. Wodrich,et al.  Influence of cargo size on Ran and energy requirements for nuclear protein import , 2002, The Journal of cell biology.

[71]  A. Baiker,et al.  Nuclear scaffold/matrix attached region modules linked to a transcription unit are sufficient for replication and maintenance of a mammalian episome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[72]  G. Hatzivassiliou,et al.  Safety-modified episomal vectors for human gene therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[73]  D. Lauffenburger,et al.  Methylation of episomal plasmids as a barrier to transient gene expression via a synthetic delivery vector. , 2001, Biomolecular engineering.

[74]  G. Natsoulis,et al.  Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome , 1997, Journal of virology.

[75]  T. Dull,et al.  Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease. , 2002, Blood.

[76]  T. Jenuwein,et al.  Extension of chromatin accessibility by nuclear matrix attachment regions , 1997, Nature.

[77]  N. Philpott,et al.  Efficient Integration of Recombinant Adeno-Associated Virus DNA Vectors Requires a p5-rep Sequence in cis , 2002, Journal of Virology.

[78]  M. Kay,et al.  Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo , 2004, Gene Therapy.

[79]  S. Sandmeyer,et al.  A Chimeric Ty3/Moloney Murine Leukemia Virus Integrase Protein Is Active In Vivo , 1998, Journal of Virology.

[80]  T. Hawley,et al.  Performance- and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator , 2003 .

[81]  Paul Shinn,et al.  HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots , 2002, Cell.

[82]  M. Kay,et al.  Epstein‐Barr Virus Vectors Provide Prolonged Robust Factor IX Expression in Mice , 2003, Biotechnology progress.

[83]  Daniel G. Miller,et al.  Adeno-associated virus vectors integrate at chromosome breakage sites , 2004, Nature Genetics.

[84]  Michael Kipp,et al.  SAF-Box, a Conserved Protein Domain That Specifically Recognizes Scaffold Attachment Region DNA , 2000, Molecular and Cellular Biology.

[85]  R. Herzog,et al.  Induction of antigen-specific CD4+ T-cell anergy and deletion by in vivo viral gene transfer. , 2004, Blood.

[86]  N. Copeland,et al.  Gene Therapy Insertional Mutagenesis Insights , 2004, Science.

[87]  Eric C. Olivares,et al.  Nucleofection of muscle-derived stem cells and myoblasts with phiC31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblasts. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[88]  B. Sauer,et al.  Brief expression of a GFP cre fusion gene in embryonic stem cells allows rapid retrieval of site-specific genomic deletions. , 1997, Nucleic acids research.

[89]  W. Stemmer.  Rapid evolution of a protein in vitro by DNA shuffling , 1994, Nature.

[90]  J. Mcarthur,et al.  Epitope Mapping of Human Anti-Adeno-Associated Virus Type 2 Neutralizing Antibodies: Implications for Gene Therapy and Virus Structure , 2000, Journal of Virology.

[91]  D. Kipling,et al.  Generation of a human X‐derived minichromosome using telomere‐associated chromosome fragmentation. , 1995, The EMBO journal.

[92]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[93]  K. Choo,et al.  A functional neo-centromere formed through activation of a latent human centromere and consisting of non-alpha-satellite DNA , 1997, Nature Genetics.

[94]  Eric C. Olivares,et al.  Phage R4 integrase mediates site-specific integration in human cells. , 2001, Gene.

[95]  J. Wolff,et al.  Efficient expression of naked dna delivered intraarterially to limb muscles of nonhuman primates. , 2001, Human gene therapy.

[96]  S. Randell,et al.  Loss of Binding and Entry of Liposome-DNA Complexes Decreases Transfection Efficiency in Differentiated Airway Epithelial Cells* , 1997, The Journal of Biological Chemistry.

[97]  F. Ascenzioni,et al.  Functional human CFTR produced by a stable minichromosome , 2002, EMBO reports.

[98]  C. Balagué,et al.  Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome , 1997, Journal of virology.

[99]  F. Jönsson,et al.  An episomally replicating vector binds to the nuclear matrix protein SAF‐A in vivo , 2002, EMBO reports.

[100]  J. Decaprio,et al.  Cul7/p185/p193 Binding to Simian Virus 40 Large T Antigen Has a Role in Cellular Transformation , 2004, Journal of Virology.

[101]  S. A. Chow,et al.  Correct integration mediated by integrase-LexA fusion proteins incorporated into HIV-1. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[102]  C. Toniatti,et al.  Lipofection of Purified Adeno-Associated Virus Rep68 Protein: toward a Chromosome-Targeting Nonviral Particle , 1998, Journal of Virology.

[103]  C. Xiao,et al.  Nuclear targeting signal recognition: a key control point in nuclear transport? , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[104]  P. Marschall,et al.  Transfer of YACs up to 2.3 Mb intact into human cells with polyethylenimine , 1999, Gene Therapy.

[105]  H. Telenius,et al.  Stability of a Functional Murine Satellite DNA-based Artificial Chromosome Across Mammalian Species , 2004, Chromosome Research.

[106]  P. Khavari,et al.  Stable nonviral genetic correction of inherited human skin disease , 2002, Nature Medicine.

[107]  Peter G Schultz,et al.  Directed evolution of the site specificity of Cre recombinase , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[108]  B. Thyagarajan,et al.  Mammalian genomes contain active recombinase recognition sites. , 2000, Gene.

[109]  A. Murray,et al.  Construction of artificial chromosomes in yeast , 1983, Nature.

[110]  H. Mizukami,et al.  Targeted Integration of Foreign DNA Into a Defined Locus on Chromosome 19 in K562 Cells Using AAV-Derived Components , 2001, International journal of hematology.

[111]  A. Fischer,et al.  Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. , 2002, The New England journal of medicine.

[112]  D. Schindelhauer,et al.  Stable gene expression from a mammalian artificial chromosome , 2001, EMBO reports.

[113]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[114]  C. von Kalle,et al.  Murine Leukemia Induced by Retroviral Gene Marking , 2002, Science.

[115]  C. Coutelle,et al.  An araC-controlled Bacterialcre Expression System to Produce DNA Minicircle Vectors for Nuclear and Mitochondrial Gene Therapy* , 2001, The Journal of Biological Chemistry.

[116]  W. Earnshaw,et al.  Functional complementation of a genetic deficiency with human artificial chromosomes. , 2001, American journal of human genetics.

[117]  D. Jans,et al.  Using nuclear targeting signals to enhance non‐viral gene transfer , 2002, Immunology and cell biology.

[118]  K. Choo,et al.  Construction of neocentromere-based human minichromosomes by telomere-associated chromosomal truncation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[119]  N. Philpott,et al.  A p5 integration efficiency element mediates Rep-dependent integration into AAVS1 at chromosome 19 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[120]  Alan McClelland,et al.  AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. , 2003, Blood.

[121]  F André,et al.  DNA electrotransfer: its principles and an updated review of its therapeutic applications , 2004, Gene therapy.

[122]  R. Jaenisch,et al.  A method for high efficiency YAC lipofection into murine embryonic stem cells. , 1996, Nucleic acids research.

[123]  J. Davoust,et al.  CD4+CD25+ regulatory T cells inhibit immune-mediated transgene rejection. , 2003, Blood.

[124]  Jennifer Nichols,et al.  A structurally defined mini-chromosome vector for the mouse germ line , 2000, Current Biology.

[125]  X. Guan,et al.  Human artificial chromosomes generated by modification of a yeast artificial chromosome containing both human alpha satellite and single-copy DNA sequences. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[126]  A. Baiker,et al.  Mitotic stability of an episomal vector containing a human scaffold/matrix-attached region is provided by association with nuclear matrix , 2000, Nature Cell Biology.

[127]  Fulvio Mavilio,et al.  Gene therapy , 1993, Nature.

[128]  T. Flotte,et al.  Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors , 2001, Gene Therapy.

[129]  K. Ozawa,et al.  Positive and negative effects of adeno-associated virus Rep on AAVS1-targeted integration. , 2003, The Journal of general virology.

[130]  B. Sauer,et al.  Nuclear targeting determinants of the phage P1 cre DNA recombinase. , 1999, Nucleic acids research.

[131]  K. Choo,et al.  Construction of neocentromere-based human minichromosomes for gene delivery and centromere studies , 2002, Gene Therapy.

[132]  P. Khavari,et al.  Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue. , 2003, The Journal of clinical investigation.

[133]  S. Dymecki.  Flp recombinase promotes site-specific DNA recombination in embryonic stem cells and transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[134]  H. Willard,et al.  Formation of de novo centromeres and construction of first-generation human artificial microchromosomes , 1997, Nature Genetics.

[135]  T. Rabbitts,et al.  The LMO2 T-Cell Oncogene Is Activated via Chromosomal Translocations or Retroviral Insertion during Gene Therapy but Has No Mandatory Role in Normal T-Cell Development , 2003, Molecular and Cellular Biology.

[136]  M. Kolot,et al.  Site-specific recombination in mammalian cells expressing the Int recombinase of bacteriophage HK022 – Site-specific recombination in mammalian cells promoted by a phage integrase , 1999, Molecular Biology Reports.

[137]  A. Baiker,et al.  A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells. , 1999, Nucleic acids research.

[138]  O. Danos,et al.  Successful Interference with Cellular Immune Responses to Immunogenic Proteins Encoded by Recombinant Viral Vectors , 2001, Journal of Virology.

[139]  C. von Kalle,et al.  Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis. , 2003, Blood.

[140]  L. Frappier,et al.  The DNA segregation mechanism of Epstein–Barr virus nuclear antigen 1 , 2000, EMBO reports.

[141]  G. Ciliberto,et al.  Conditional Site-Specific Integration into Human Chromosome 19 by Using a Ligand-Dependent Chimeric Adeno-Associated Virus/Rep Protein , 2000, Journal of Virology.

[142]  R. Cortese,et al.  Targeted integration of adeno-associated virus-derived plasmids in transfected human cells. , 1998, Virology.

[143]  Ernst Wagner,et al.  Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. , 2003, Bioconjugate chemistry.

[144]  W. Brown,et al.  Mini-chromosomes derived from the human Y chromosome by telomere directed chromosome breakage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[145]  M. Kolot,et al.  Site-specific recombination in mammalian cells expressing the Int recombinase of bacteriophage HK022. , 1999, Molecular biology reports.

[146]  Kazuo Maruyama,et al.  Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system. , 2004, Biochemistry.

[147]  R. Cortese,et al.  Development of Animal Models for Adeno-Associated Virus Site-Specific Integration , 1999, Journal of Virology.

[148]  R. Samulski,et al.  Roles of Adeno-Associated Virus Rep Protein and Human Chromosome 19 in Site-Specific Recombination , 2000, Journal of Virology.

[149]  K. Matsumoto,et al.  Induction of DNA replication by transcription in the region upstream of the human c-myc gene in a model replication system , 1996, Molecular and cellular biology.